During the preclinical drug testing stage, conventional test subjects include animals and cells cultured in a lab, which are costly, and cannot correctly represent human tissue. Therefore, these test subjects may inaccurately predict human response to a drug and may falsely demonstrate a drug as “safe”. Upon public distribution, unexpected side effects may occur, which […]
Read More